PSORIASIS AND DIABETES MELLITUS :A STUDY ON THE CO-RELATION BETWEEN PSORIASIS AREA AND SEVERITY INDEX (PASI) AND FASTING BLOOD SUGAR LEVELS.

Dr. Anju Antony, Ms. Neethu Thomas

Abstract


Background : Psoriasis is a multisystem inflammatory disease with predominantly skin and joint involvement. Psoriasis is
associated with an increased risk of Diabetes Mellitus independent of major risk factors in a manner that co-relates with the
severity of Psoriasis. The present study is an attempt to study the co-relation between PASI and FBS.
Methods : This was a cross-sectional study conducted in the Department of Dermatology at a tertiary care centre in South India.
Psoriatic patients attending the outpatient department were enrolled in the study and examined after taking informed consent.
Results : The most common type of Psoriasis observed was palmoplantar psoriasis, followed by chronic plaque psoriasis. The
male: female ratio was 1:1. The PASI score was found to be lower in females compared to males. A significant positive co-relation
between PASI and FBS was observed in our study. There was no association between duration of topical steroid therapy and FBS.
Conclusion : The most common clinical type of psoriasis observed was palmoplantar psoriasis. There is a significant positive co
relation between PASI and FBS. The PASI scores were lower in females compared to males. There was no association between
duration of topical steroid therapy and FBS.


Keywords


Psoriasis, Diabetes, PASI

Full Text:

PDF

References


Whan B.Kim, Dana Jerome,Jensen Yeung. Diagnosis and

management of psoriasis.Can Fam Physician 2017 Apr;63(4);278-285.

Carvalho, et al. Psoriasis comorbidities : complications and benefits of immunological treatment. An Bras Dermatol 2016;91(6):781-789.

Cohen AD,et.al Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol .2008,22,585-589.

Langley RG,et.al .Evaluating Psoriasis with Psoriasis Area and Severity Index,Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment. J Am Acad Dermatol.2004,51(4),563-569.

Klaassen KM, et al . Scoring nail psoriasis. J Am Acad Dermatol.2014;70(6):1061-1066.

Gelfand MJ.Psoriasis,Type 2 Diabetes mellitus ,and Obesity.Weighing the evidence.JAMA Dermatol 2016 Jul 1;152(7):753-754.

Uva .L et.al. Mechanisms of action of topical corticosteroidsin psoriasis. Int J Endocrinol.2012; 2012:561018

Hengge UR, et al. J Am Acad Dermatol.2006 Jan;54(1):1-15

Bedi TR. Psoriasis in North India. Geographical variations. Dermatologica 1977;155:310-314.

Kaur I, Handa S, Kumar B. Natural history of psoriasis.A study from the Indian subcontinent. J Dermatol 1997;24:230-234.

Hagg D,et al. Severity of psoriasis differs between men and women: A study of the clinical outcome measure psoriasis area and severity index(PASI) in 5438 Swedish Register Patients. Am J Clin Dermatol.2017 Aug ;18(4):583-590.

Farber EM, et al . The natural history of psoriasis in 5600 patients.Dermatologica 1974;148:1-18

Bedi TR. Clinical profile of psoriasis in north India. Indian J Dermatol Venereol Leprol1995;61:202-205.

Bakr .GH, et.al. Metabolic syndrome and elevated osteopontin: their associated co-morbidities in patients with psoriasis.


Refbacks

  • There are currently no refbacks.